Modern Diagnostic Methods in Ewing's Sarcoma Family: Six Patients With Histologic Soft Tissue Tumors

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Soft tissue tumors pose diagnostic challenges, impacting patient prognosis and treatment.
• Ewing's sarcoma (ES) family tumors frequently exhibit a specific t(11;22) translocation.
• Accurate diagnosis of soft tissue tumors is critical for effective patient management.

Purpose of the Study:

• To evaluate a diagnostic method for identifying Ewing's sarcoma family tumors.
• To assess the utility of combined immunohistochemistry, cytogenetics, and PCR for ES diagnosis.
• To improve the diagnostic accuracy of challenging soft tissue tumor cases.

Main Methods:

• Utilized immunohistochemistry with MIC2 marker.
• Performed cytogenetic analysis.
• Employed nested reverse transcription-polymerase chain reaction (RT-PCR) for the t(11;22) translocation.
• Examined both fresh-frozen and formalin-fixed, paraffin-embedded archival material.

Main Results:

• Four out of six patients were initially diagnosed with ES family tumors.
• The applied diagnostic methods confirmed ES family tumors in all six cases.
• The study successfully identified the characteristic t(11;22) translocation in relevant cases.

Conclusions:

• The integrated diagnostic approach (MIC2 IHC, cytogenetics, RT-PCR) is highly effective for diagnosing Ewing's sarcoma family tumors.
• This method enhances diagnostic accuracy for soft tissue tumors, even when initial diagnoses are uncertain.
• The findings support the routine use of this comprehensive technique in soft tissue tumor pathology.